The aim of this study was to provide evidence for the hypothesis that estimated glomerular filtration rate from serum Cystatin C (eGFRcys) is better to be determined for all elderly type 2 diabetes mellitus (T2DM) patients based on eGFRcys upward and downward reclassification rate for hypothetical metformin dose reduction by eGFRcys at the GFR decision point of 45 mL/min/1.73 m2 . A total of 265 consecutive T2DM elderly patients (age range 65-91 years) from outpatient diabetic clinic were included in the study. The Kidney Disease Improving Global Outcomes (KDIGO) guidelines for metformin dosing were strictly followed. Estimated glomerular filtration rate from serum creatinine (eGFRcrea) led to results of metformin eligibility. Each of the results of eGFRcrea-based eligibility was further compared to eGFRcys-based eligibility. Creatinine was measured by enzymatic method standardized against international reference material SRM 967. Cystatin C was determined by method traceable to DA ERM 471 international standard. eGFRcrea and eGFRcys were calculated according to Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations. A downward reclassification rate was higher than upward reclassification rate (31 vs 3, respectively; P < 0.0001). The median (IQR) eGFRcrea was higher than eGFRcys (73 (58-85) vs 63 (50-75) mL/min/1.73 m2 , respectively; P < 0.0001). eGFRcys reclassified significant proportion of patients with T2DM from metformin eligible CKD stages to less or non-eligible stages. The downward reclassification was more frequent in patients older than 80 years (P < 0.01). Cystatin C-based eGFR selects more complicated patients, where lower doses of metformin are possibly advisable. We recommend calculating both eGFRcrea and eGFRcys for metformin dosing in elderly patients with T2DM.

Department of Biomedical sciences Medical Faculty University of Ostrava Ostrava Zábřeh Czech Republic

Department of Clinical Biochemistry and Pharmacology Tomas Bata Hospital in Zlín a s Zlín Czech Republic

Diabetes Center Tomas Bata Hospital in Zlín a s Zlín Czech Republic

See more in PubMed

Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60:1577‐1585. PubMed PMC

Fuček M, Dika Ž, Karanović S, et al. Reliability of CKD‐EPI predictive equation in estimating chronic kidney disease prevalence in the Croatian endemic nephropathy area. Biochem Med (Zagreb). 2018;28:010701 10.11613/BM.2018.010701. PubMed DOI PMC

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO . clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;2013(3):1‐163.

American Diabetes Association . 10. Microvascular complications and foot care. Diabetes Care. 2018;41:S105‐S118. PubMed

Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and Cystatin C. N Engl J Med. 2012;367:20‐29. PubMed PMC

Nyborg PT, Bergmann TK, Lykkesfeldt J. Basic & clinical pharmacology & toxicology policy for experimental and clinical studies. Basic Clin Pharmacol Toxicol. 2018;123:233‐235. PubMed

Tuot DS, Scherzer R, Leong H, Hung AM, Grunfeld C, Shlipak MG. Use of Cystatin C to inform metformin eligibility among adult veterans with diabetes. J Clin Transl Endocrinol. 2016;3:1‐6. PubMed PMC

Pottel H, Delanaye P, Weekers L, et al. Age‐dependent reference intervals for estimated and measured glomerular filtration rate. Clin Kidney J. 2017;10:545‐551. PubMed PMC

Shardlow A, McIntyre NJ, Fraser SDS, et al. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: a primary care cohort study. PLoS Med. 2017;14:e1002400. PubMed PMC

Klee GG, Schryver PG, Saenger AK, Larson TS. Effects of analytic variations in creatinine measurements on the classification of renal disease using estimated glomerular filtration rate (eGFR). Clin Chem Lab Med. 2007;45:737‐741. PubMed

Šálek T, Ponížil P. Estimated glomerular filtration rate in diabetic patients. Klin Biochem Metab. 2014;22:4‐7.

Jabor A, Franeková J, Kubíček Z, Šálek T. Estimated glomerular filtration rate and problems in the interpretation of CKD‐EPI equations (Short communication – data expansion and comments to the article “Estimated glomerular filtration rate in diabetic patients” published by Šálek T. and Ponížil P.). Klin Biochem Metab 2014;22:8‐10.

Fan L, Inker LA, Rossert J, et al. Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test. Nephrol Dial Transplant. 2014;29:1195‐1203. PubMed PMC

Delanaye P, Cavalier E, Moranne O, Lutteri L, Krzesinski J‐M, Bruyère O. Creatinine‐or cystatin C‐based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease. BMC Nephrol. 2013;14:57. PubMed PMC

Waheed S, Matsushita K, Sang Y, et al. Combined association of albuminuria and cystatin C‐based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2012;60:207‐216. PubMed PMC

Brown CS, Kashani KB, Clain JM, Frazee EN. Cystatin C falsely underestimated GFR in a critically ill patient with a new diagnosis of AIDS. Case Rep Nephrol. 2016;2016:9349280 10.1155/2016/9349280. Available from: http://downloads.hindawi.com/journals/crin/2016/9349280.pdf. Accessed Sep 5, 2018 PubMed DOI PMC

Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75:652‐660. PubMed PMC

Misbin RI. The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care. 2004;27:1791‐1793. PubMed